BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29500664)

  • 21. Effect of stereotactic radiosurgery before bilateral adrenalectomy for Cushing's disease on the incidence of Nelson's syndrome.
    Mehta GU; Sheehan JP; Vance ML
    J Neurosurg; 2013 Dec; 119(6):1493-7. PubMed ID: 23952749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypopituitarism after stereotactic radiosurgery for pituitary adenomas.
    Xu Z; Lee Vance M; Schlesinger D; Sheehan JP
    Neurosurgery; 2013 Apr; 72(4):630-7; 636-7. PubMed ID: 23277375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes of stereotactic radiosurgery for foramen magnum meningiomas: an international multicenter study.
    Mehta GU; Zenonos G; Patibandla MR; Lin CJ; Wolf A; Grills I; Mathieu D; McShane B; Lee JY; Blas K; Kondziolka D; Lee CC; Lunsford LD; Sheehan JP
    J Neurosurg; 2018 Aug; 129(2):383-389. PubMed ID: 28862549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma knife radiosurgery is a successful adjunctive treatment in Cushing's disease.
    Castinetti F; Nagai M; Dufour H; Kuhn JM; Morange I; Jaquet P; Conte-Devolx B; Regis J; Brue T
    Eur J Endocrinol; 2007 Jan; 156(1):91-8. PubMed ID: 17218730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotactic radiosurgery for idiopathic glossopharyngeal neuralgia: an international multicenter study.
    Kano H; Urgosik D; Liscak R; Pollock BE; Cohen-Inbar O; Sheehan JP; Sharma M; Silva D; Barnett GH; Mathieu D; Sisterson ND; Lunsford LD
    J Neurosurg; 2016 Dec; 125(Suppl 1):147-153. PubMed ID: 27903192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pituitary radiotherapy for Cushing's disease.
    Losa M; Picozzi P; Redaelli MG; Laurenzi A; Mortini P
    Neuroendocrinology; 2010; 92 Suppl 1():107-10. PubMed ID: 20829629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Retrospective analysis to evaluate efficacy and safety of stereotactic radiosurgery in Cushing's disease: 24 cases and a review].
    Roldán Serrano MA; Horcajadas Almansa A; Torres Vela E; Sánchez Corral C; Moliz Molina N
    Neurocirugia (Astur); 2016; 27(4):167-75. PubMed ID: 27020252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution.
    Kong DS; Lee JI; Lim DH; Kim KW; Shin HJ; Nam DH; Park K; Kim JH
    Cancer; 2007 Aug; 110(4):854-60. PubMed ID: 17599761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Long-Term Study of the Treatment of Nelson's Syndrome With Gamma Knife Radiosurgery.
    Caruso JP; Patibandla MR; Xu Z; Vance ML; Sheehan JP
    Neurosurgery; 2018 Sep; 83(3):430-436. PubMed ID: 28950324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gamma knife radiosurgery in patients with persistent acromegaly or Cushing's disease: long-term risk of hypopituitarism.
    Cohen-Inbar O; Ramesh A; Xu Z; Vance ML; Schlesinger D; Sheehan JP
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):524-31. PubMed ID: 26341248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Whole Sella vs Targeted Stereotactic Radiosurgery for Acromegaly: A Multicenter Matched Cohort Study.
    Taylor DG; Janssen A; Ding D; Xu Z; Mehta GU; Liscak R; Kano H; Kosak M; Martinez-Moreno N; Hobbs L; Chen CJ; Grills IS; Mathieu D; Lunsford LD; Vance ML; Sheehan JP
    Neurosurgery; 2020 May; 86(5):656-664. PubMed ID: 31384920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility and outcome of re-irradiation in the treatment of multiply recurrent pituitary adenomas.
    Verma J; McCutcheon IE; Waguespack SG; Mahajan A
    Pituitary; 2014 Dec; 17(6):539-45. PubMed ID: 24272035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Update on the management of recurrent Cushing's disease.
    Rutkowski MJ; Flanigan PM; Aghi MK
    Neurosurg Focus; 2015 Feb; 38(2):E16. PubMed ID: 25639318
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CyberKnife for the management of Cushing's disease: our institutional experience and review of literature.
    Abdali A; Kalinin PL; Trunin YY; Astaf'Eva LE; Shkarubo AN; Chmutin GE; Chavda V; Golanov A; Abdali B; Chernov IV; Vats A; Chaurasia B
    Br J Neurosurg; 2021 Oct; 35(5):578-583. PubMed ID: 33955316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurocognitive changes in pituitary adenoma patients after Gamma Knife radiosurgery.
    Tooze A; Sheehan JP
    J Neurosurg; 2018 Dec; 129(Suppl1):55-62. PubMed ID: 30544290
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target delineation and optimal radiosurgical dose for pituitary tumors.
    Minniti G; Osti MF; Niyazi M
    Radiat Oncol; 2016 Oct; 11(1):135. PubMed ID: 27729088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of Cushing's disease. Transsphenoidal surgery and pituitary radiotherapy].
    Lamas Oliveira C; Estrada García J
    Endocrinol Nutr; 2009 Mar; 56(3):123-31. PubMed ID: 19627725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation therapy and stereotactic radiosurgery for the treatment of Cushing's disease: an evidence-based review.
    Starke RM; Williams BJ; Vance ML; Sheehan JP
    Curr Opin Endocrinol Diabetes Obes; 2010 Aug; 17(4):356-64. PubMed ID: 20531182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy for refractory Cushing's disease.
    Sherry AD; Khattab MH; Xu MC; Kelly P; Anderson JL; Luo G; Utz AL; Chambless LB; Cmelak AJ; Attia A
    Pituitary; 2019 Dec; 22(6):607-613. PubMed ID: 31552580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of whole-sellar gamma knife radiosurgery for magnetic resonance imaging-negative Cushing's disease.
    Durankus NK; Samanci Y; Yilmaz M; Sengoz M; Bolukbasi Y; Peker S
    J Neurosurg Sci; 2023 Aug; 67(4):414-421. PubMed ID: 32989971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.